These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


398 related items for PubMed ID: 17211730

  • 1. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY.
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [Abstract] [Full Text] [Related]

  • 2. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
    Kashibuchi K, Tomita K, Schalken JA, Kume H, Takeuchi T, Kitamura T.
    Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
    [Abstract] [Full Text] [Related]

  • 3. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K, Tomita K, Schalken JA, Kume H, Yamaguchi T, Muto S, Horie S, Kitamura T.
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [Abstract] [Full Text] [Related]

  • 4. L1, β-catenin, and E-cadherin expression in patients with colorectal cancer: correlation with clinicopathologic features and its prognostic significance.
    Fang QX, Lü LZ, Yang B, Zhao ZS, Wu Y, Zheng XC.
    J Surg Oncol; 2010 Oct 01; 102(5):433-42. PubMed ID: 20672319
    [Abstract] [Full Text] [Related]

  • 5. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S, Liu J, Li G, Mo F, Xu X, Zhang T, Zhang X, Li J, Han X, Sun Y.
    Scand J Gastroenterol; 2008 Oct 01; 43(4):456-64. PubMed ID: 18365911
    [Abstract] [Full Text] [Related]

  • 6. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R, Kimura N, Harada Y, Ohuchi N.
    Int J Oncol; 2001 Mar 01; 18(3):513-20. PubMed ID: 11179480
    [Abstract] [Full Text] [Related]

  • 7. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K, Ajiki T, Okazaki T, Horiuchi H, Fujita T, Kuroda Y.
    Oncology; 2006 Mar 01; 71(1-2):102-10. PubMed ID: 17341890
    [Abstract] [Full Text] [Related]

  • 8. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ, Hwang SE, Yu HC, Moon WS.
    Oncol Rep; 2009 Jan 01; 21(1):57-63. PubMed ID: 19082443
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H, Fujimori T, Fujii S, Ichikawa K, Ohkura Y, Tomita S, Ono Y, Imura J, Kuroda Y.
    Dis Colon Rectum; 2005 May 01; 48(5):938-45. PubMed ID: 15785891
    [Abstract] [Full Text] [Related]

  • 10. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
    Ngan CY, Yamamoto H, Seshimo I, Ezumi K, Terayama M, Hemmi H, Takemasa I, Ikeda M, Sekimoto M, Monden M.
    J Surg Oncol; 2007 Jun 15; 95(8):652-62. PubMed ID: 17443723
    [Abstract] [Full Text] [Related]

  • 11. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
    Choi SY, Jo YS, Huang SM, Liang ZL, Min JK, Hong HJ, Kim JM.
    Hum Pathol; 2011 Oct 15; 42(10):1476-83. PubMed ID: 21496863
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer.
    Kwak JM, Min BW, Lee JH, Choi JS, Lee SI, Park SS, Kim J, Um JW, Kim SH, Moon HY.
    Dis Colon Rectum; 2007 Nov 15; 50(11):1873-80. PubMed ID: 17828401
    [Abstract] [Full Text] [Related]

  • 13. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J, Ikeguchi M, Nakamura S, Kaibara N.
    J Exp Clin Cancer Res; 2002 Mar 15; 21(1):65-71. PubMed ID: 12071532
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical prognostic factors in resected colorectal lung metastases using tissue microarray analysis.
    Shiono S, Ishii G, Nagai K, Murata Y, Tsuta K, Nitadori J, Kodama T, Ochiai A.
    Eur J Surg Oncol; 2006 Apr 15; 32(3):308-9. PubMed ID: 16459049
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY, Karaçetin D, Kabukçuoğlu F, Taşkin T, Yener Ş.
    Pol J Pathol; 2011 Apr 15; 62(1):19-24. PubMed ID: 21574102
    [Abstract] [Full Text] [Related]

  • 16. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
    Ramesh S, Nash J, McCulloch PG.
    Br J Cancer; 1999 Dec 15; 81(8):1392-7. PubMed ID: 10604738
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
    Ohno T, Aihara R, Kamiyama Y, Mochiki E, Asao T, Kuwano H.
    Eur J Cancer; 2006 Jan 15; 42(2):256-63. PubMed ID: 16356709
    [Abstract] [Full Text] [Related]

  • 18. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS, Jang KS, Song YS, Jang SH, Min KW, Han HX, Na W, Lee KH, Choi D, Jang SJ.
    Ann Surg Oncol; 2007 Dec 15; 14(12):3453-9. PubMed ID: 17882496
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM.
    J Clin Pathol; 2006 May 15; 59(5):460-7. PubMed ID: 16461565
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.
    Ann Surg Oncol; 2008 May 15; 15(5):1530-7. PubMed ID: 18259822
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.